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Abstract  
 
Purpose 
 
Every health care sector including hospice / palliative care needs to systematically improve services 
using patient-defined outcomes. Data from the national Australian Palliative Care Outcomes 
Collaboration aims to define whether hospice / palliative care patients’ outcomes and the consistency 
of these outcomes have improved in the last three years. 
 
Methods 
 
Data were analysed by clinical phase (stable, unstable, deteriorating, terminal). Patient-level data 
included the Symptom Assessment Scale and the Palliative Care Problem Severity Score. 
 
Nationally collected point-of-care data were anchored for the period July-December 2008 and 
subsequently compared to this baseline in six six-monthly reporting cycles for all services that 
submitted data in every time period (n=30) using individual longitudinal multi-level random 
coefficient models  
 
Results 
 
Data were analysed for 19,747 patients (46% female; 85% cancer; 27,928 episodes of care; 65,463 
phases). There were significant improvements across all domains (symptom control, family care, 
psychological and spiritual care) except pain. Simultaneously, the inter-quartile ranges decreased, 
jointly indicating that better and more consistent patient outcomes were being achieved. 
 
Conclusion 
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These are the first national hospice / palliative care symptom control performance data to demonstrate 
improvements in clinical outcomes at a service level as a result of routine data collection and 
systematic feedback.   
 
Keywords: palliative care, symptom control, performance measurement, clinical benchmarking 
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Introduction 
 
Every part of the health care system needs to systematically improve the services that it offers, 
including hospice / palliative care. Like other health care providers, it is important for hospice / 
palliative care to measure patient-defined outcomes and to continually strive to improve the care that 
is offered. Previous work has helped to conceptualise key domains that relate to quality of care and 
characterise meaningful outcomes within the setting of life-limiting illnesses [1-3]. Continued work is 
required to develop further and measure meaningful outcomes beyond crude indices such as mortality 
or simple process measures that may or may not actually improve patient outcomes. 
 
Key parameters for the systematic introduction of performance improvement include: 
1. Selecting measures that are meaningful to patients, their caregivers and clinicians; 
2. Using tools that can inform policy and funding decisions systematically; 
3. Embedding systems to collect these measures in routine clinical practice and analyse them in a 
standard way nationally; 
4. Ensuring that the performance of individual services can be tracked longitudinally using the same 
measures to evaluate changes in the quality of care; 
5. Providing timely and respectful mechanisms for feedback of each service’s performance; and 
6. At a systems level, working to understand the key factors that drive changes in performance 
through benchmarking and ensuring that services apply best-available evidence for the changes 
required to improve outcomes. 
 
The care provided by specialist palliative care services in Australia reaches a wide range of people 
with life-limiting illnesses although this is still predominantly people whose diagnosis is cancer. From 
population estimates, the percentage of people with life limiting illnesses in Australia who are referred 
to specialist palliative care services is just under 60% across the community [4].  
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With the challenges generated by clinical practice in hospice / palliative care and a dedicated 
workforce utilising limited resources, there is a need to ensure that every service is delivering the best 
possible care to the people who most need that care [5]. An essential prerequisite of a quality service 
is to have in place sufficiently robust measures to ensure patients’ needs and outcomes can be 
assessed systematically in routine practice. Another pre-requisite is that there is close collaboration 
between peer services in order to participate in benchmarking, refine models of care and continue to 
improve outcomes systematically. 
 
In order to undertake meaningful benchmarking, there needs to be ways to compare patient outcomes 
in a small rural service with those in a large university teaching hospital. The focus is therefore on 
individual patients’ measurements regardless of setting, as it is patients’ outcomes that ultimately 
define quality of care. These data are aggregated to service level comparisons.  
 
This patient-centred approach requires systematically collecting outcome measures at point-of-care in 
order to inform areas where improvements need to occur [6,7]. It also requires methods to control for 
differences in the mix of patients seen in different services (age, gender, life-limiting illnesses, 
prognosis), given that hospice / palliative care services have differing patterns of referral [8].  
 
The Australian Palliative Care Outcomes Collaboration is a national program funded by the federal 
Department of Health that is designed to improve clinical outcomes in palliative care through an 
explicit audit and feedback quality cycle that includes: 
 
1. National service level performance derived from patient outcome measures; 
2. Systematic benchmarking between participating services or relevant sub-groups of them. This 
involves measuring each service against national benchmark standards that PCOC sets and 
reports against; 
3. Actively implementing quality improvement initiatives. While each service implements their 
own quality improvement programs, nationally employed staff facilitate identifying priorities 
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for clinical and systems change, and support change management processes across each 
participating service through communities of practice (Quality Improvement Facilitators 
(QIFs); 
4. For individual patients, outcomes are recorded at each encounter (if in the community) and at 
least with each phase change (in hospital); and  
5. Aggregate data are analysed and reported back to participating services allowing comparison 
to all other participating (deidentified) services nationally every six months.  
 
Important principles underpinning participation in the initiative include that it is voluntary, data are 
owned by the service submitting them and there is timely return of analysed, comparative data to each 
participating service where only the service receiving the data know their own actual performance. All 
other data are anonymised. Participating services are supported throughout the process by receiving 
training in standardised clinical assessment, interpreting and using the data, and ways of optimising 
quality improvement programs. More detail on PCOC and its operation and progress has been 
reported previous [6,7] as well as at http://www.pcoc.org.au/. 
 
The aims of this study were to determine whether hospice / palliative care services’ patients’ and 
caregivers’ outcomes have improved nationally since the inception of point-of-care data collection, 
structured and timely feedback and benchmarking by PCOC and also whether there was greater 
consistency in service performance. The null hypothesis was that there was no difference between the 
performance of services over baseline during the study period. 
 
 
Methods 
 
Nationally consistent clinical assessments are collected by participating services at every clinical 
encounter with the patient (in the community) and at least with every phase change (in hospital), 
whether care was provided directly or through consultative services. This is derived from a point-of-
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care data collection.    An ‘episode of care’ changes each time the setting of care changes (community 
care, inpatient care, specialist nursing facility). Phase of care are clinically relevant categories of care 
that describe the palliative care trajectory [9]. Within this routine point-of-care collection, data are 
therefore aggregated at episode and phase level in order to help to compare similar sub-populations. 
(Table 1; collected when a person’s clinical condition changes) [9,10]. 
 
The Palliative Care Phase of Care is a measure of relative resource utilisation linked directly to 
clinical needs, irrespective of diagnosis or prognosis [9,10] . There are four clinical phases for the 
patient: stable, unstable, deteriorating and terminal and a fifth (bereavement phase) when specific 
bereavement support is provided to the family. Movement between phases is determined by clinical 
needs and the urgency of the interventions required. A new phase is assigned whenever a clinical 
change requires patient/family reassessment and modification of the care plan. 
 
Work has been undertaken to identify quality measures in hospice / palliative care [11,12]. In PCOC, 
symptoms are measured using two key measures.  The seven domains of the Symptom Assessment 
Scale measure insomnia; appetite; nausea; bowels; breathing; fatigue and pain on a 0-10 numerical 
patient self-rating scale [13,14]. The four domains of the clinician-rated Palliative Care Problem 
Severity Score capture pain; other (physical) symptoms; psychological/spiritual problems; and 
family/carer problems measured as a categorical scale (absent, mild, moderate or severe) [10].   
 
In the service feedback report for January – June 2009, PCOC introduced eight Casemix Adjusted 
Relative Mean Improvement (CARMI) [15] measures for each of the measures in the clinician-rated 
Palliative Care Problem Severity Score (pain, other symptoms, family/carer problems and 
psychological/spiritual problems) and for 4 items in the patient- (or proxy-) rated Symptom 
Assessment Score (pain, nausea, breathing problems and bowel problems). The CARMI is a risk-
adjustment methodology that measures the difference between the change in pain and symptom scores 
achieved and what was expected. The ‘expected’ scores are based on what was actually achieved for 
different classes of patients (the ‘casemix’) during a baseline period in July – December 2008. The 
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CARMI measures allow services to compare themselves to this national baseline and to each other, 
taking into account the different mix of patients at each service. This score was calculated by 
averaging the change for each patient in the same phase (stable, unstable, deteriorating, terminal) with 
the symptom score at the start of the phase in order to create the baseline expected change score. This 
forms the anchor point against which changes in services’ performances (improving or worsening) 
were assessed longitudinally, ensuring that patient-level data compared similar patients. 
 
Analysis 
 
Data for the eight routinely reported casemix adjusted relative mean improvement measures were 
analysed at phase level in six month periods for all of the services in the Collaboration that provided 
data in all six (January 1, 2009 to December 31, 2011) six- monthly reporting periods and score 
changes compared to the baseline. For each service in each six monthly report, this figure was 
averaged across all phases. 
 
For each measure, a longitudinal multi-level random coefficient model was fitted to determine 
whether there was a significant, positive increase in the proportion of phases that were better than 
baseline over the three year period. 
 
Consent and ethical oversight 
 
The study was approved by the Human Research Ethics Committee of the University of Wollongong, 
the auspicing body for the Collaboration. Individually identified data were not collected. Data 
collection was of routine clinical data and separate consent was not required to be sought for this. 
 
 
Results 
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Data from all 30 services who were continuously engaged in the PCOC audit and feedback process 
between January 2009 and December 2011 were included in the analysis. These 30 services varied in 
their service delivery models and geographic settings (Table 2) and from other participating services 
whose data were not provided for all six periods and from those services who are not participating.  
(Table 2) The total number of episodes of care they reported was 27,928 with 65,463 phase of care. 
For services, the mean and median numbers of patients, and episodes and phases of care increased in 
each six month period. (Table 3) 
 
At a patient level, these data report the care provided to 19,747 patients of whom 46% were female 
and 85% of whom had cancer as their primary life-limiting illness. Mean age was 70.9 years (SD 
14.3; median 73; range 0-103). 
 
For both patient- and clinician-reported outcomes, there were statistically significant improvements in 
all domains over the three year period at a service level with the exception of pain. (Table 4)  
Consistent with this, the median service level percentage of patient phases achieving at least the 
baseline median change increased incrementally over the period. At the same time, the service level 
inter- quartile ranges also decreased in the same domains over the same period of reporting suggesting 
that not only was overall performance improving, but outcomes were being achieved more 
consistently. (Table 5; Figure 1) 
 
 
Discussion 
 
This is the first time that national hospice / palliative care performance data in symptom control have 
been presented, and the first data that demonstrate that patient-centred improvements in care can be 
delivered nationally. This program of work demonstrates that it is feasible to measure patient-centred 
palliative care outcomes routinely at point-of-care as an integral part of the clinical encounter. More 
importantly, the data confirm that it is possible to work with services to improve systematically the 
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care that is provided in ways that can be measured using patient- and family-centred outcomes. Work 
is ongoing to better understand why pain is the only symptom not to significantly improve. 
 
Other initiatives have started around the world that are seeking to routinely improve patient outcomes 
through routine data capture, analysis and feedback using similar processes [16-18]. There is a need to 
harmonise measures and ensure that data are also being benchmarked at patient-level across these 
initiatives to understand variations in outcomes between services internationally.   
 
Building routine data collection into clinical care is the critical foundation in order to understand 
patient outcomes. This allows comparison between patients, not simply between services. 
Demonstrating the rates of improved symptom control is crucial if, as a community, we are to have 
confidence in the care that is offered to people at the end of life and to further invest in it. 
 
Given that hospice / palliative care was a sector of health care that was largely data naïve a decade 
ago, a national voluntary program of this size and complexity demonstrates very rapid progress. For 
many services for the first time, the Collaboration has embedded standardised and routine clinical 
assessments. More importantly, PCOC has catalysed a process of services starting to compare and 
contrast models of service delivery and levels of resourcing in ways that have not happened before.  
 
Strengths of this program 
Bespoke measures important to patients and their families cannot be derived from clinical records and 
need to be collected prospectively.  These data fulfil this crucial criterion. The diversity of settings 
make such collection even more crucial, and this study represents the various clinical settings in 
which hospice / palliative clinical care is delivered.  
 
By using phase and a measure of function, PCOC has also embedded a new common language for 
rapidly describing the position on the care trajectory of individual patients [19]. 
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The use of these two simple measures (phase and function) to describe each patient also allows for 
data standardisation across the palliative care population in a way that has not been possible before. 
This includes an ability for referring health professionals and specialist service providers to use 
descriptors with agreed definitions to describe a person’s physical status accurately and quickly. 
 
By controlling for patients’ overall physical status (which is the major predictor of resource utilisation 
at the end of life) in the comparisons made, residual variations are largely going to be due to 
variations between services: models of care; clinical competencies; resourcing; or combinations of 
these factors.  This has allowed a process of embedding quality systematically across a whole sector 
of the health system relatively quickly. Developing a culture of rapid evaluation and re-evaluation 
after adjusting local models of clinical care delivery is an exciting development within hospice / 
palliative care.  
 
Data collected in this prospective way are of high quality because their collection is built into routine 
clinical practice. Tools used clinically on a day-to-day basis to measure and plan patient care can be 
captured and, from  a service’s perspective, be used to follow performance over time with a small 
number of key measures that are important to patients and their families. The simplicity of the 
measures is a major strength especially with the ability to complement this work with direct patient 
and family / caregiver surveys. 
 
Limitations 
 
This analysis is limited to those services that participated for the entire 42 month period, and although 
they may not be entirely representative of all services, they represent a range of service models in a 
range of settings and provide care to a large number of patients. Importantly, the finding that patient-
centred outcomes can be improved is in no way diminished by the number of services. 
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These data can only reflect people who are referred to specialist palliative care services, and this 
currently represents about 60% of people who will die from cancer with much lower rates for other 
life-limiting illnesses [20].  Extending this data collection into primary care to cover the balance of 
patients is going to be far more challenging.  Further development of the data system will enhance the 
ability to follow individual patients across a range of settings of care.  
 
Staff competency in clinical ratings is an area of ongoing training and calibration. There is also an 
unquantifiable level of proxies making clinical ratings on behalf of patients, but this has 
systematically diminished over the course of the data reported here and would likely therefore serve to 
underestimate the magnitude of improvement reported. Quantifying the discrepancy between patient 
and proxy ratings has been an important part of this process [14].  
 
Implications for research 
 
These data are a demonstration of what can be measured nationally on a routine basis. However, these 
data are not sufficient to explain why similarly resourced services have different patient outcomes. 
Differences in clinical outcomes between services as a result of differing staffing levels can also be 
deduced from the PCOC processes.  This is work that needs to be done urgently. Equally, research on 
why pain is the only symptom not to significantly improve is also urgent.  
 
There is the challenge of whether service level improvements are translating into improvements at an 
individual patient level at a level that is clinically meaningful. As numbers increase in the dataset, 
sub-group analyses will also be able to be undertaken by site of care and by diagnostic sub-groups.  
 
Implications for clinical practice and quality improvement 
 
The quality of hospice / palliative care can be improved, but this requires performance to be measured 
routinely by the people for whom it most counts – patients. Without such measurement, it is tempting 
13 
 
to rely on the praise and gratitude of families who have experienced the services offered. Given these 
data, it is difficult to justify any service that does not actively include measurement of the service’s 
performance and use these data to drive quality improvement processes. 
 
Implications for health policy 
 
The community-wide benefits of hospice / palliative care services include benefits for patients and 
their families / caregivers [21]. Ensuring that the services offered systematically improve is likely to 
amplify the benefits that have already been observed. Given the increasing levels of investment in 
hospice / palliative care services by health services, it is crucial to expand the evidence base that 
supports improved health outcomes for people at the end of life, and for caregivers while in the role 
and subsequently. These data also suggest that funders can now consider linking funding levels to 
patient-centred quality outcomes. 
 
Conclusions 
Although the outcomes are encouraging, this program of work also highlights the continued deficits 
that exist in symptom control. Only by systematic and routine measurement can the magnitude of this 
be identified and addressed. The process of addressing each individual service’s performance is being 
addressed by PCOC staff (Quality Improvement Facilitators) who work alongside every participating 
service to identify areas for improvement, define interventions to be implemented and help to monitor 
the subsequent outcomes. 
 
Ultimately, this study demonstrates that meaningful outcomes can be routinely collected in hospice / 
palliative care and, that by providing a feedback loop and service to service benchmarking, patient-
focused improvements can be delivered.  
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Table 1 Phase definitions* 
 
Phase 1: Stable 
All patients not classified as unstable, deteriorating, or terminal. 
 
The patient symptoms are adequately controlled by established management. Further 
interventions to maintain symptom control and quality of life have been planned. 
 
The situation of the family/carers is relatively stable and no new issues are apparent. Any 
needs are met by the established plan of care. 
Phase 2: Unstable 
The patient experiences the development of a new unexpected problem or a rapid increase in the 
severity of existing problems, either of which require an urgent change in management or 
emergency treatment 
 
The family/carers experience a sudden change in their situation requiring urgent intervention by 
members of the multidisciplinary team 
Phase 3: Deteriorating 
The patient experiences a gradual worsening of existing symptoms or the development of new but 
expected problems. These require the application of specific plans of care and regular review but 
not urgent or emergency treatment. 
 
The family/carers experience gradually worsening distress and other difficulties, including social 
and practical difficulties, as a result of the illness of the person. This requires a planned support 
program and counselling as necessary. 
Phase 4: Terminal 
Death is likely in a matter of days and no acute intervention is planned or required.  The 
typical features of a person in this phase may include the following: 
 
Profoundly weak; essentially bed bound; 
Drowsy for extended periods 
Disoriented for time and has a severely limited attention span 
Increasingly disinterested in food and drink 
Finding it difficult to swallow medication 
 
This requires the use of frequent, usually daily, interventions aimed at physical, emotional and 
spiritual issues. 
 
The family/carers recognise that death is imminent and care is focussed on emotional and 
spiritual issues as a prelude to bereavement. 
 
Phase 5: Bereaved 
 
Death of the patient has occurred and the carers are grieving. A planned bereavement support 
program is available including referral for counselling as necessary.  Record only one 
bereavement phase per patient - not one for each carer/family member. 
 
 
*These are the phase definitions used at the time of these data being collected. There is a 
revised set of definitions now being used that include more definitive data about when a phase 
ends (rather than simply relying on the beginning of the next phase). 
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Table 2: Characteristics of the 30 services that contributed data for all six monthly 
collection periods January 2009 to December 2011 in the Australian Palliative Care 
Outcomes Collaboration.  
 
 
Type of clinical service 
 
n (%) Inpatient Ambulatory/community 
Both 
Inpatient & 
community/ 
ambulatory 
Total 
Services 
included in the 
study 
Geographic 
setting for 
care 
delivery 
Metropolitan 7 (23) 1 (3) 4 (13) 12 (40) 
Regional / rural 5 (17) 3 (10) 7 (23) 15 (50) 
Both metropolitan & regional / rural 0 (0) 2 (7) 1 (3) 3 (10) 
Total 12 (40) 6 (20) 12 (40) 30 (100) 
All services 
submitting data 
during July – 
December 2011 
Geographic 
setting for 
care 
delivery 
Metropolitan 23 (23) 9 (10) 15 (15) 47 (46) 
Regional / rural 19 (19) 12 (12) 14 (14) 45 (44) 
Both metropolitan & regional / rural 7 (7) 2 (2) 1 (1) 10 (10) 
Total 49 (48) 23 (23) 30 (29) 102 (100) 
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Table 3: Changes in caseload, episodes and phases of care over time in the 30 services that 
provided data in all six monthly periods participating in the Australian Palliative Care 
Outcomes Collaboration. 
 
 n 
Jan-Jun  
2009 
Jul-Dec  
2011 
Total Jan 
2009- Dec 
2011 
Patients 3,006 3,808 19,747
Episodes of care 3,886 5,039 27,928
Phases of care 8,372 11,656 65,463
  
Number of episodes 
of care reported per 
service 
Mean 129.5 168.0
Std. Dev. 120.3 162.8
Median 91 94
Range 12-457 23-643
 
Number of phases 
of care reported per 
service 
Mean 279.1 388.5
Std. Dev. 238.1 375.0
Median 201.5 232
Range 16-805 51-1475
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Table 4: Regression coefficients (standard errors) of fixed effects from the multi-level models 
 
Clinical Assessment 
Tool 
Domain/Symptom Intercept Time (slope) 
Palliative Care  
Problem Severity 
Score 
Pain 0.668 (0.020)** 0.002 (0.006) 
Other Symptoms 0.517 (0.027)** 0.021 (0.005)** 
Family/carer 0.492 (0.034)** 0.023 (0.006)** 
Psychological 
spiritual 
0.590 (0.028)** 0.028 (0.005)** 
Symptom 
Assessment Scale 
Pain 0.064 (0.022)** 0.004 (0.006) 
Nausea 0.749 (0.021)** 0.020 (0.004)** 
Breathing problems 0.663 (0.018)**  0.016 (0.004)* 
Bowel problems 0.598 (0.027)** 0.025 (0.006)** 
* p < 0.01, ** p < 0.001 
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Table 5 – Service level percentage of patient phases achieving at least the baseline average change – 
median and inter-quartile ranges over time of the 30 services participating continuously in the 
Australian Palliative Care Outcomes Collaboration for key domains of care. 
 
Jan – Jun 
2009 
Jul- Dec 
2009 
Jan – Jun 
2010 
Jul- Dec 
2010 
Jan – Jun 
2011 
Jul- Dec 
2011 
*PCPSS: Pain 
Median 65% 68% 66% 67% 70% 69% 
Interquartile Range 18% 13% 11% 10% 12% 14% 
   
PCPSS: Other 
Symptoms 
Median 48% 50% 56% 61% 59% 62% 
Interquartile Range 23% 25% 22% 15% 15% 16% 
    
PCPSS: Family 
Carer 
Median 48% 52% 56% 55% 59% 60% 
Interquartile Range 24% 22% 23% 12% 13% 20% 
   
PCPSS: 
Psychological 
Spititual 
Median 59% 63% 67% 67% 69% 73% 
Interquartile Range 22% 22% 15% 16% 18% 9% 
   
**SAS: Pain 
Median 64% 65% 62% 65% 64% 66% 
Interquartile Range 20% 16% 15% 13% 14% 12% 
   
SAS: Nausea 
Median 76% 81% 83% 80% 82% 84% 
Interquartile Range 17% 14% 14% 11% 9% 10% 
   
SAS: Difficulty 
Breathing 
Median 68% 66% 71% 71% 71% 75% 
Interquartile Range 19% 12% 8% 8% 11% 15% 
   
SAS: Bowel 
Problems 
Median 65% 68% 66% 67% 70% 69% 
Interquartile Range 18% 13% 11% 10% 12% 14% 
*Palliative Care Problem Severity Score 
** Symptom Assessment Score 
 
